ArticlePharmaceuticals (Basel, Switzerland)2024

Role of Dapagliflozin in Ischemic Preconditioning in Patients with Symptomatic Coronary Artery Disease-DAPA-IP Study Protocol.

Marco Alexander Valverde Akamine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.